3B BlackBio Dx Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Share holding
• Capital structures
• Ratio

Sep ' 23	Sep ' 22	Mar ' 22	Sep ' 21	Sep ' 20

Sales

31.78

6.24

7.59

7.93

7.66

Operating profit

15.35

-0.27

-1.18

-0.06

-0.51

Interest

0.05

0.09

0.01

0.10

0.15

Gross profit

21.00

2.75

-0.18

8.93

1.72

EPS (Rs)

18.62

3.23

-0.54

11.20

1.74

Other income

5.71

3.12

1.01

9.08

2.38

Stock adjustment

0.32

-0.37

0.19

0.08

0.58

Raw material

10.17

4.37

5.52

4.50

5.21

Power and fuel

-

-

-

-

-

Employee expenses

2.50

0.94

0.82

0.75

0.84

Excise

-

-

-

-

-

Admin and selling expenses

-

-

-

-

-

Research and development expenses

-

-

-

-

-

Expenses capitalised

-

-

-

-

-

Other expenses

3.43

1.56

2.24

2.66

1.53

Provisions made

-

-

-

-

-

Depreciation

0.40

0.14

0.19

0.11

0.11

Taxation

4.66

0.19

0.04

0.42

0.31

Net profit / loss

15.95

2.43

-0.40

8.41

1.31

Extra ordinary item

-

-

-

-

-

Prior year adjustments

-

-

-

-

-

Equity capital

8.57

7.51

7.51

7.51

7.51

Equity dividend rate

-

-

-

-

-

Agg.of non-prom. shares (Lacs)

-

-

-

-

-

Agg.of non promotoholding (%)

-

-

-

-

-

OPM (%)

48.31

-4.32

-15.49

-0.72

-6.62

GPM (%)

56.03

29.44

-2.06

52.50

17.17

NPM (%)

42.54

25.94

-4.68

49.43

13.00